Management of Hyponatremia
Hyponatremia management requires a systematic approach based on acuity (acute vs. chronic), symptom severity, and volume status, with correction rates never exceeding 8 mmol/L in 24 hours to prevent osmotic demyelination syndrome. 1
Initial Assessment and Classification
Determine the acuity of onset by establishing whether hyponatremia developed over less than 48 hours (acute) or more than 48 hours (chronic), as this fundamentally changes the safety profile of correction rates. 1 Acute hyponatremia can be corrected more rapidly without risk of osmotic demyelination, while chronic cases require cautious correction. 1
Assess symptom severity immediately to guide urgency of intervention. 1 Severe symptoms include seizures, coma, altered consciousness, confusion, delirium, and respiratory distress—these constitute a medical emergency requiring immediate hypertonic saline. 1, 2 Mild to moderate symptoms include nausea, vomiting, muscle cramps, gait instability, lethargy, weakness, headaches, and dizziness. 2
Evaluate volume status through physical examination looking for specific findings: hypovolemic signs (orthostatic hypotension, dry mucous membranes, decreased skin turgor, flat neck veins), hypervolemic signs (peripheral edema, ascites, jugular venous distention, pulmonary congestion), or euvolemic appearance (absence of both). 1 Physical examination alone has limited accuracy (sensitivity 41%, specificity 80%), so laboratory parameters should guide assessment. 1
Obtain essential laboratory workup including serum and urine osmolality, urine sodium concentration, urine electrolytes, serum uric acid, and assessment of extracellular fluid volume status. 1 Check thyroid-stimulating hormone to rule out hypothyroidism and assess renal function with creatinine and blood urea nitrogen. 1
Treatment Based on Symptom Severity
Severe Symptomatic Hyponatremia (Medical Emergency)
Administer 3% hypertonic saline immediately with an initial goal to correct 6 mmol/L over 6 hours or until severe symptoms resolve. 1, 3 Give 100 mL boluses over 10 minutes, which can be repeated up to three times at 10-minute intervals. 1
Monitor serum sodium every 2 hours during initial correction of severe symptoms. 1, 3 After severe symptoms resolve, transition to checking every 4 hours and switch to protocols for mild symptoms or asymptomatic hyponatremia. 3
Discontinue 3% saline when severe symptoms resolve, then implement fluid restriction to 1 L/day and continue monitoring. 3 After the initial 6 mmol/L correction, limit additional correction to only 2 mmol/L in the following 18 hours. 3
Mild to Moderate Symptomatic or Asymptomatic Hyponatremia
Treatment depends critically on volume status, as each category requires opposite therapeutic approaches.
Treatment Based on Volume Status
Hypovolemic Hyponatremia
Discontinue diuretics immediately and administer isotonic saline (0.9% NaCl) for volume repletion. 1 Initial infusion rate should be 15-20 mL/kg/h, then 4-14 mL/kg/h based on response. 1
Urinary sodium <30 mmol/L has a positive predictive value of 71-100% for response to saline infusion, confirming the diagnosis of hypovolemic hyponatremia. 1 Once euvolemia is achieved, reassess and adjust management accordingly. 1
Euvolemic Hyponatremia (SIADH)
Implement fluid restriction to 1 L/day as the cornerstone of treatment for SIADH. 1, 3 If no response to fluid restriction, add oral sodium chloride 100 mEq three times daily. 1
For severe symptomatic cases, use 3% hypertonic saline with careful monitoring as described above. 1 Pharmacological options for resistant cases include vasopressin receptor antagonists (tolvaptan 15 mg once daily, titrate to 30-60 mg), demeclocycline, lithium, or urea. 1
Distinguish SIADH from cerebral salt wasting (CSW) in neurosurgical patients, as they require opposite treatments. 1 SIADH is characterized by euvolemia, urine sodium >20-40 mmol/L, and urine osmolality >300 mOsm/kg. 1 CSW presents with hypovolemia, urine sodium >20 mmol/L despite volume depletion, and requires volume and sodium replacement, not fluid restriction. 1
Hypervolemic Hyponatremia (Heart Failure, Cirrhosis)
Implement fluid restriction to 1-1.5 L/day for serum sodium <125 mmol/L. 1 Temporarily discontinue diuretics if sodium <125 mmol/L. 1
Consider albumin infusion alongside fluid restriction in cirrhotic patients (8 g per liter of ascites removed). 1 Avoid hypertonic saline unless life-threatening symptoms are present, as it may worsen ascites and edema. 1
In cirrhosis, sodium restriction (not fluid restriction) results in weight loss as fluid passively follows sodium. 1 Recommend salt intake of 2-2.5 g/day (88-110 mmol/day). 1
Critical Correction Rate Guidelines
Never exceed 8 mmol/L correction in any 24-hour period to prevent osmotic demyelination syndrome. 1, 3 This is the single most important safety principle in hyponatremia management. 1
For high-risk patients (advanced liver disease, alcoholism, malnutrition, prior encephalopathy), use even more cautious correction at 4-6 mmol/L per day, with an absolute maximum of 8 mmol/L in 24 hours. 1 These patients have a 0.5-1.5% risk of osmotic demyelination syndrome even with careful correction. 1
Calculate sodium deficit using the formula: Desired increase in Na (mEq/L) × (0.5 × ideal body weight in kg). 1 This helps determine the appropriate amount of sodium supplementation needed. 1
Special Populations and Considerations
Neurosurgical Patients
Cerebral salt wasting requires volume and sodium replacement with isotonic or hypertonic saline, never fluid restriction. 1 For severe symptoms, use 3% hypertonic saline plus fludrocortisone (0.1-0.2 mg daily) in ICU setting. 1
In subarachnoid hemorrhage patients at risk of vasospasm, avoid fluid restriction as it worsens outcomes and increases risk of cerebral ischemia. 1 Consider fludrocortisone to prevent vasospasm and hydrocortisone to prevent natriuresis. 1
Cirrhotic Patients
Hyponatremia in cirrhosis increases risk of spontaneous bacterial peritonitis (OR 3.40), hepatorenal syndrome (OR 3.45), and hepatic encephalopathy (OR 2.36). 1 Even mild hyponatremia may indicate worsening hemodynamic status. 1
Vasopressin receptor antagonists (tolvaptan) can be used for short-term treatment but carry higher risk of gastrointestinal bleeding (10% vs 2% placebo) in cirrhotic patients. 1 Use with extreme caution and reserve for refractory cases. 1
Management of Overcorrection
If sodium correction exceeds 8 mmol/L in 24 hours, immediately discontinue current fluids and switch to D5W (5% dextrose in water). 1 Consider administering desmopressin to slow or reverse the rapid rise in serum sodium. 1
Target is to bring the total 24-hour correction back to ≤8 mmol/L from the starting point. 1 Watch for signs of osmotic demyelination syndrome (dysarthria, dysphagia, oculomotor dysfunction, quadriparesis) typically occurring 2-7 days after rapid correction. 1
Common Pitfalls to Avoid
Never ignore mild hyponatremia (130-135 mmol/L) as clinically insignificant—it increases hospital mortality 60-fold (11.2% vs 0.19%) and is associated with cognitive impairment, falls (21% vs 5%), and fractures. 1, 2, 4, 5
Never use fluid restriction in cerebral salt wasting—this worsens outcomes and can be fatal. 1 Always distinguish CSW from SIADH in neurosurgical patients before initiating treatment. 1
Never correct chronic hyponatremia faster than 8 mmol/L in 24 hours—overly rapid correction causes osmotic demyelination syndrome. 1 Rapid correction (>1 mmol/L/hour) should only be used for severely symptomatic acute hyponatremia. 3
Never use hypertonic saline in hypervolemic hyponatremia without life-threatening symptoms—it worsens fluid overload, ascites, and edema. 1 Fluid restriction is the appropriate first-line therapy. 1
Inadequate monitoring during active correction is a critical error. 1 Serum sodium must be checked every 2 hours during severe symptomatic correction, then every 4 hours after symptom resolution. 1, 3